The Asia-Pacific cardiovascular ultrasound market is projected to register a CAGR of 6.61% during the forecast period, 2022-2030, and reach a revenue of $653.03 million by 2030.

ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET FORECAST 2022-2030

Asia-Pacific Cardiovascular Ultrasound Market by Display (Black and White, Color) Market by Technology (2D, 3D/4D, Doppler) Market by Type (Transthoracic Echocardiography, Fetal Echocardiography, Transesophageal Echocardiography, Other Types) Market by End-user (Hospitals, Diagnostic Centers, Ambulatory Care Centers, Other End-users) By Geography

Request free sample

The Asia-Pacific cardiovascular ultrasound market is projected to register a CAGR of 6.61% during the forecast period, 2022-2030, and reach a revenue of $653.03 million by 2030.

The continual technological advancements like artificial intelligence have positively impacted cardiology in the region by facilitating advanced diagnostic capabilities for certain heart conditions. However, the market growth is restrained by the expenses involved in setting up the entire cardiovascular ultrasound infrastructure. Such factors influence the Asia-Pacific cardiovascular ultrasound market growth.

Asia Pacific Cardiovascular Ultrasound Market

To know more about this report, request a free sample copy

The Asia-Pacific cardiovascular ultrasound market growth assessment includes the analysis of South Korea, India, Japan, China, Australia & New Zealand, Taiwan, Singapore, Indonesia, and Rest of Asia-Pacific. The main risk factors for cardiovascular diseases are obesity/overweight, family history, physical inactivity, smoking, diabetes, high cholesterol, and high blood pressure. In South Korea, heart disease has been the leading cause of death for almost a decade. Cardiovascular disease mortality was on a decline until 2010, inclining at a steady rate of 123 per 100,000 in 2018. Additionally, in 2018, around 12.1 million adults had hypertension, and 4.3 million had diabetes. Accordingly, the five major cardiovascular disease risk factors evaluated were smoking, obesity, hypercholesterolemia, diabetes, and hypertension. Besides, several companies are prioritizing advanced technologies for the healthcare sector that will help in the timely diagnosis of cardiovascular diseases. For instance, Samsung Medison offers products like an ultrasound system, portable CT, and digital radiography.

In Singapore, according to varied sources (Ministry of Health, Immigration and Checkpoints Authority, Singapore, and Report on Registration of Births and Deaths 2021), 21 people die from cardiovascular diseases every day. Also, as per the same sources, in 2021, cardiovascular diseases accounted for 32% of all deaths.

The Asia-Pacific cardiovascular ultrasound market segmentation includes end-user, type, technology, and display. The type category includes transesophageal echocardiography, fetal echocardiography, transthoracic echocardiography, and other types.

Transesophageal echocardiography is a test used to get a detailed picture of the heart. High-frequency sound waves are used that create a detailed image of the heart and arteries. The sound waves are generated from the echo transducer/probe attached to a thin tube that passes through the mouth, down the throat, and into the patient’s esophagus.

Also, transesophageal echocardiography offers detailed and clear images of the esophagus that aid the doctors in checking the size of the heart and thickness of its walls, abnormal tissue around heart valves that could indicate fungal, viral, or bacterial infections, blood clots, etc. Additionally, the test is used to get precise information during surgeries to repair heart valves and tears in the aorta or congenital heart lesions during the surgical treatment for endocarditis. There are no severe risks associated with the test.

The other echocardiography types include intracardiac echocardiography, stress echocardiography, etc. Stress echocardiography, also known as a stress echo, determines the proper functioning of the heart and blood vessels. The test is done over a treadmill or stationary bike, wherein the doctors monitor the heart rhythm and blood pressure. It aids doctors in diagnosing coronary artery disease and heart attack risks, thereby enabling proper, timely treatment.

Some of the prominent companies in the Asia-Pacific cardiovascular ultrasound market include Mindray Medical International Limited, Lanmage, Leltek, Philips Healthcare, etc.

Leltek is specialized in wireless ultrasound device development and manufacture. The company focuses on providing access to ultrasound devices in emergency rooms, home care, ambulances, and clinics, alongside offering quality medical care in remote areas. The company has partners in the Middle East, Asia, Europe, and North America, with headquarters in New Taipei City, Taiwan.

One of its key products, LeSONO Linear Probe, can be utilized for varied applications like thyroid, breast, carotid, vascular, etc.

Report ScopeDetails
Market Forecast Years2022-2030
Base Year2021
Market Historical Years2018-2021
Forecast UnitsRevenue ($ Million)
Segments AnalyzedEnd-User, Type, Technology, Display
Countries AnalyzedSouth Korea, India, Japan, China, Australia & New Zealand, Taiwan, Singapore, Indonesia, and Rest of Asia-Pacific
Companies Analyzed

Canon Medical Systems Corporation, Clarius, Dawei Medical, Esaote SpA, Fujifilm Holdings Corporation, GE Healthcare, Lanmage, Leltek, Mindray Medical International Limited, Philips Healthcare, Samsung Medison Co Ltd, Siemens Healthineers, Telemed Ultrasound Medical Systems, Viatom Technology Co, Zoncare

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISING CARDIOVASCULAR DISEASES
        • TECHNOLOGICAL ADVANCEMENTS
      • KEY RESTRAINTS
        • LACK OF AWARENESS AMONG PATIENTS
        • STRINGENT REGULATIONS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CARDIOVASCULAR ULTRASOUND MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
        • QUALITY
        • DURABILITY
        • PRICE
        • TECHNOLOGY
    1. MARKET BY DISPLAY
      • BLACK AND WHITE
      • COLOR
    2. MARKET BY TECHNOLOGY
      • 2D
      • 3D/4D
      • DOPPLER
    3. MARKET BY TYPE
      • TRANSTHORACIC ECHOCARDIOGRAPHY
      • FETAL ECHOCARDIOGRAPHY
      • TRANSESOPHAGEAL ECHOCARDIOGRAPHY
      • OTHER TYPES
    4. MARKET BY END-USER
      • HOSPITALS
      • DIAGNOSTIC CENTERS
      • AMBULATORY CARE CENTERS
      • OTHER END-USERS
    5. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • SINGAPORE
          • TAIWAN
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • CANON MEDICAL SYSTEMS CORPORATION
        • CLARIUS
        • DAWEI MEDICAL
        • ESAOTE SPA
        • FUJIFILM HOLDINGS CORPORATION
        • GE HEALTHCARE
        • LANMAGE
        • LELTEK
        • MINDRAY MEDICAL INTERNATIONAL LIMITED
        • PHILIPS HEALTHCARE
        • SAMSUNG MEDISON CO LTD
        • SIEMENS HEALTHINEERS
        • TELEMED ULTRASOUND MEDICAL SYSTEMS
        • VIATOM TECHNOLOGY CO
        • ZONCARE

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – CARDIOVASCULAR ULTRASOUND

    TABLE 2: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 3: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 4: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 5: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 6: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 7: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 8: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 9: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 10: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 11: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 12: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET

    TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS          

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: VALUE CHAIN ANALYSIS

    FIGURE 6: KEY BUYING CRITERIA

    FIGURE 7: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY DISPLAY, IN 2021

    FIGURE 8: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2030 (IN $ MILLION)

    FIGURE 9: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COLOR, 2022-2030 (IN $ MILLION)

    FIGURE 10: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

    FIGURE 11: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2030 (IN $ MILLION)

    FIGURE 12: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2030 (IN $ MILLION)

    FIGURE 13: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2030 (IN $ MILLION)

    FIGURE 14: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

    FIGURE 15: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2030 (IN $ MILLION)

    FIGURE 16: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2030 (IN $ MILLION)

    FIGURE 17: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2030 (IN $ MILLION)

    FIGURE 18: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2030 (IN $ MILLION)

    FIGURE 19: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

    FIGURE 20: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)

    FIGURE 21: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)

    FIGURE 22: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2030 (IN $ MILLION)

    FIGURE 23: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)

    FIGURE 24: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 25: CHINA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 26: JAPAN CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 27: INDIA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 28: SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 29: INDONESIA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 30: SINGAPORE CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 31: TAIWAN CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 32: AUSTRALIA & NEW ZEALAND CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 33: REST OF ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)       

    1. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • SINGAPORE
          • TAIWAN
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. MARKET BY DISPLAY
      • BLACK AND WHITE
      • COLOR
    2. MARKET BY TECHNOLOGY
      • 2D
      • 3D/4D
      • DOPPLER
    3. MARKET BY TYPE
      • TRANSTHORACIC ECHOCARDIOGRAPHY
      • FETAL ECHOCARDIOGRAPHY
      • TRANSESOPHAGEAL ECHOCARDIOGRAPHY
      • OTHER TYPES
    4. MARKET BY END-USER
      • HOSPITALS
      • DIAGNOSTIC CENTERS
      • AMBULATORY CARE CENTERS
      • OTHER END-USERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type